Trial · NCT00548652
Role of Apathy in the Effectiveness of Weight Loss Interventions
NCT00548652, Not applicable, Completed, VA Nebraska Western Iowa Health Care System; results first posted 2019-10-04
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Role of Apathy in the Effectiveness of Weight Loss Interventions. Trials, record NCT00548652. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00548652
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Role of Apathy in the Effectiveness of Weight Loss Interventions
- NCT number
- NCT00548652
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 101 participants, actual
- Lead sponsor
- VA Nebraska Western Iowa Health Care System
- Conditions
- Obesity, Apathy
- Interventions
- MOVE, medical crisis councelling, MOVE, methyphenidate, MOVE, methyphenidate, medical crisis councelling, MOVE
- First posted
- 2007-10-24
- Last updated
- 2019-10-04
- Results first posted
- 2019-10-04
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Apathy Evaluation Scale | 6 months | Apathy Evaluation Scale (AES) measures apathy over the previous four weeks Scale range: 18 (minimum score)- 72 (Maximum score) Higher scores indicate higher apathy Better outcome would be reduction in the score |
| Secondary | Change in Weight | 6 months | value at 6 months minus value at baseline |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Apathy Evaluation Scale | 6 months | units on a scale | MEAN | |
| SECONDARY | Change in Weight | 6 months | Kg | MEAN |
Source ClinicalTrials.gov
Results by group6
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Apathy Evaluation Scale | Usual Care | -7.69 | Standard Deviation 6.77 | units on a scale | |
| Apathy Evaluation Scale | VA MOVE | -6.4 | Standard Deviation 7.35 | units on a scale | |
| Apathy Evaluation Scale | Intervention | -6.15 | Standard Deviation 8.3 | units on a scale | |
| Change in Weight | Usual Care | -0.6 | Standard Deviation 3.73 | Kg | |
| Change in Weight | VA MOVE | -0.61 | Standard Deviation 7.14 | Kg | |
| Change in Weight | Intervention | -4.61 | Standard Deviation 9.42 | Kg |
Source ClinicalTrials.gov
Participant flow9
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Usual Care | 18 | |
| Overall Study | STARTED | VA MOVE | 38 | |
| Overall Study | STARTED | Intervention | 45 | |
| Overall Study | COMPLETED | Usual Care | 16 | |
| Overall Study | COMPLETED | VA MOVE | 29 | |
| Overall Study | COMPLETED | Intervention | 34 | |
| Overall Study | NOT COMPLETED | Usual Care | 2 | |
| Overall Study | NOT COMPLETED | VA MOVE | 9 | |
| Overall Study | NOT COMPLETED | Intervention | 11 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals9
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Usual Care | 0 | 18 |
| Total, all-cause mortality | VA MOVE | 0 | 38 |
| Total, all-cause mortality | Intervention | 0 | 45 |
| Total, other adverse events | Usual Care | 0 | 18 |
| Total, other adverse events | VA MOVE | 0 | 38 |
| Total, other adverse events | Intervention | 0 | 45 |
| Total, serious adverse events | Usual Care | 0 | 18 |
| Total, serious adverse events | VA MOVE | 0 | 38 |
| Total, serious adverse events | Intervention | 0 | 45 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00548652
GET https://conductscience.org/api/trials/v1/NCT00548652/registered